- ISIN
- US71944F1066
- CUSIP
- 71944F106
- Sector
- Healthcare
- Industry
- Health Information Services
- IPO Date
- Jul 18, 2019
Highlights
- Market Cap
- $553.40M
- Enterprise Value
- $564.89M
- EPS (TTM)
- $0.21
- PE Ratio
- 42.88
- Total Revenue (TTM)
- $495.59M
- Gross Profit (TTM)
- $329.85M
- EBITDA (TTM)
- $32.08M
- Year Range
- $7.77 - $32.76
- Target Price
- $21.86
- ROA (TTM)
- 1.91%
- ROE (TTM)
- 3.54%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
PHR Performance Chart
Phreesia, Inc. (PHR) is down 47.3% since the beginning of the year. At $9 per share, PHR is trading 72.8% below its 52-week high of $33. Investors who bought $1,000 worth of PHR shares 5 years ago would now be looking at an investment worth $150.
Loading charts...
Returns By Period
Phreesia, Inc. (PHR) has returned -47.28% so far this year and -65.97% over the past 12 months.
Phreesia, Inc.
- 1D
- -4.90%
- 1M
- 0.00%
- YTD
- -47.28%
- 6M
- -45.84%
- 1Y
- -65.97%
- 3Y*
- -33.53%
- 5Y*
- -31.57%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
PHR Monthly Returns History
Based on dividend-adjusted daily data since Jul 18, 2019, PHR's average daily return is +0.01%, while the average monthly return is -0.04%.
Historically, 45% of months were positive and 55% were negative. The best month was Dec 2023 with a return of +50.2%, while the worst month was Sep 2023 at -34.4%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 7 months.
On a daily basis, PHR closed higher 50% of trading days. The best single day was Dec 6, 2023 with a return of +21.2%, while the worst single day was Mar 31, 2026 at -26.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -20.63% | -8.19% | -32.04% | 9.90% | 7.06% | -9.53% | -47.28% | ||||||
| 2025 | 13.12% | -6.75% | -3.69% | -2.35% | -1.88% | 16.21% | -5.27% | 17.43% | -25.71% | -3.74% | -9.50% | -17.42% | -32.75% |
| 2024 | 10.06% | -2.86% | -3.31% | -13.33% | -8.78% | 12.05% | 17.69% | 3.05% | -11.36% | -19.75% | 14.98% | 19.64% | 8.68% |
| 2023 | 15.85% | -1.84% | -12.26% | -2.01% | -5.12% | 3.30% | 2.29% | -10.25% | -34.39% | -26.87% | 12.81% | 50.23% | -28.46% |
| 2022 | -25.13% | -1.28% | -14.39% | -13.20% | -20.72% | 37.87% | -6.08% | 9.24% | -0.70% | 7.22% | 1.83% | 16.32% | -22.32% |
| 2021 | 20.33% | -6.19% | -14.94% | -0.67% | -4.35% | 23.84% | 11.50% | 4.68% | -13.77% | 14.33% | -18.23% | -27.77% | -23.22% |
Benchmark Metrics
Phreesia, Inc. has an annualized alpha of -15.14%, beta of 1.21, and R2 of 0.17 versus S&P 500 Index. Calculated based on daily prices since July 18, 2019.
- This stock participated in 148.57% of S&P 500 Index downside but only 40.08% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.17 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -15.14%
- Beta
- 1.21
- R²
- 0.17
- Upside Capture
- 40.08%
- Downside Capture
- 148.57%
Return for Risk
Risk / Return Rank
PHR ranks 5 for risk / return — in the bottom 5% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Phreesia, Inc. (PHR) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PHR | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.20 | ||
| Sortino ratioReturn per unit of downside risk | -4.61 | ||
| Omega ratioGain probability vs. loss probability | 0.73 | 1.37 | -0.64 |
| Calmar ratioReturn relative to maximum drawdown | -0.88 | 2.78 | -3.66 |
| Martin ratioReturn relative to average drawdown | -1.34 | 12.44 | -13.78 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Phreesia, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Phreesia, Inc. was 90.00%, occurring on Apr 10, 2026. The portfolio has not yet recovered.
The current Phreesia, Inc. drawdown is 88.93%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -90.00%Apr 2026 | 5y 2mo | — | 5y 4moFeb 2021 - now |
COVID crash2020 | -51.39%Mar 2020 | 23d | 7mo 7d | 8moFeb 2020 - Oct 2020 |
2019 bear market2019 | -22.04%Sep 2019 | 27d | 1mo 22d | 2mo 19dAug 2019 - Oct 2019 |
2020 correction2020 | -13.62%Jan 2020 | 2mo 7d | 10d | 2mo 17dNov 2019 - Jan 2020 |
2019 correction2019 | -10.36%Jul 2019 | 4d | 8d | 12dJul 2019 - Jul 2019 |
Drawdown Indicators
| PHR | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.00% | -56.78% | -33.22% |
Max Drawdown (1Y)Largest decline over 1 year | -75.24% | -9.10% | -66.14% |
Max Drawdown (3Y)Largest decline over 3 years | -76.65% | -18.90% | -57.75% |
Max Drawdown (5Y)Largest decline over 5 years | -89.24% | -25.43% | -63.81% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -88.93% | -1.80% | -87.13% |
Average DrawdownAverage peak-to-trough decline | -51.04% | -10.71% | -40.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 49.12% | 2.03% | +47.09% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Phreesia, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Phreesia, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for PHR, comparing it with other companies in the Health Information Services industry. Currently, PHR has a P/E ratio of 42.9. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PHR relative to other companies in the Health Information Services industry. Currently, PHR has a P/S ratio of 1.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PHR in comparison with other companies in the Health Information Services industry. Currently, PHR has a P/B value of 1.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with PHR
Add Phreesia, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with PHR